Log in
Enquire now
‌

US Patent 9650433 Modified glycoproteins

Patent 9650433 was granted and assigned to Momenta Pharmaceuticals on May, 2017 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Current Assignee
Momenta Pharmaceuticals
Momenta Pharmaceuticals
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
9650433
Patent Inventor Names
Sean Smith0
Maurice Gaston Hains0
Nathaniel J. Washburn0
Naveen Bhatnagar0
Brian Edward Collins0
Carlos J. Bosques0
Dorota A. Bulik0
James Meador0
Date of Patent
May 16, 2017
Patent Application Number
14118269
Date Filed
May 18, 2012
Patent Primary Examiner
‌
Brad Duffy
Patent abstract

Sulfated glycoproteins, and methods of making and using such sulfated glycoproteins, are described.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 9650433 Modified glycoproteins

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.